ZYNE | Zynerba Phamaceuticals Inc Category: Pharmaceutical company Quick infos Headquarters: Devon, Pennsylvania, United States Trade prices Volume: Market Cap: 161.71M Prev closed: 4.73 Open: 4.95 High: 4.95 Low: 4.57 52 week low: 2.55 52 week high: 15.7 Dividends: No Dividends Next ER: November 15, 2021
Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery.
Date EPS / Forecast Revenue / Forecast March 14, 2022 November 15, 2021 -0.26 / -0.252 - / - August 11, 2021 - / -0.2229 - / - May 12, 2021 -0.2 / -0.25 - / - March 15, 2021 - / -0.3286 - / - view more Historical Data
Date Price Open High Low Vol Change ER Jan 18, 2022 2.470 2.520
229.18K -6.08% Jan 14, 2022 2.630 2.530
926.68K 3.14% Jan 13, 2022 2.550 2.630
777.87K -3.04% Jan 12, 2022 2.630 2.730
1.26M -3.31% Jan 11, 2022 2.720 2.700
337.10K 0.74% Jan 10, 2022 2.700 2.650
548.56K 0.37% Jan 7, 2022 2.690 2.720
551.84K -0.37% Jan 6, 2022 2.700 2.670
599.30K 0.75% Jan 5, 2022 2.680 2.900
1.12M -9.15% Jan 4, 2022 2.950 3.060
509.83K -2.32% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News Zynerba Pharmaceuticals EPS misses by $0.33 seekingalpha.com Aug 10, 2020 6:54 pm Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights finance.yahoo.com Aug 10, 2020 6:45 am The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test finance.yahoo.com Aug 4, 2020 7:41 am Zynerba Pharmaceuticals (ZYNE) Outpaces Stock Market Gains: What You Should Know finance.yahoo.com Jul 29, 2020 5:50 pm Zynerba Pharmaceuticals to Present an Update on the Zygel Development Program at the 17th NFXF International Fragile X Conference Research Roundup finance.yahoo.com Jul 22, 2020 6:50 am Zynerba's Zygel flunks Fragile X study seekingalpha.com Jun 30, 2020 7:02 pm ZYNE DEADLINE: Zhang Investor Law Reminds Investors of December 23 Deadline in Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc. ZYNE finance.yahoo.com Jul 1, 2020 4:31 pm MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zynerba Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm finance.yahoo.com Jul 1, 2020 4:01 pm INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in Aurora Cannabis, Inc., and Zynerba Pharmaceuticals of Filing Deadlines finance.yahoo.com Jul 1, 2020 3:51 pm SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline ZYNE finance.yahoo.com Jul 1, 2020 3:10 pm The Week In Cannabis: Federal Spending Bill, Vaping Bans And More Corporate Carnage finance.yahoo.com Jul 1, 2020 2:21 pm Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm finance.yahoo.com Jul 1, 2020 1:43 pm Zynerba Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm finance.yahoo.com Jul 1, 2020 1:32 pm Pot Stock Short-Sellers Net Almost $1 Billion in 2019 finance.yahoo.com Jul 1, 2020 12:28 pm Zynerba Pharmaceuticals Presents Health State Utility Index Data on Severity of Fragile X Syndrome (FXS) and Diagnostic Challenges Faced by Caregivers finance.yahoo.com Jul 1, 2020 12:07 pm Is Zynerba Pharmaceuticals (ZYNE) Stock Outpacing Its Medical Peers This Year? finance.yahoo.com Jul 1, 2020 11:30 am Zynerba Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm finance.yahoo.com Jul 1, 2020 11:19 am Bronstein, Gewirtz & Grossman, LLC Alerts of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE) finance.yahoo.com Jul 1, 2020 10:35 am Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action - iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE) finance.yahoo.com Jul 1, 2020 10:34 am Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE) finance.yahoo.com Jul 1, 2020 10:32 am
This company doesn't provide a dividend.
Key Persons CEO : Armando Anido General Counsel : Suzanne M. Hanlon Chief Medical Officer : Joseph M. Palumbo (Md, Fapa, Macpsych) Talk about Zynerba Phamaceuticals Inc below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
Consensus BUY 83 HOLD 17 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via
Paypal. More features coming soon :) Buy on Amazon
In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.